Close
ACHEMA MIDDLE EAST 2026

Prothena Announces Global Neuroscience R&D Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases

Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan...

Praluent extensively reduces risk of cardiovascular events in high-risk patients, and was associated with lower death rate 

Sanofi and Regeneron Pharmaceuticals, Inc. announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the risk of major adverse...

Business Finland provides €3 Million Loan to Forendo Pharma for Developing Novel Treatments for Endometriosis

Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces that it has been granted a €3 million R&D loan...

Italian pharmaceutical R & D excellence presented at the 33rd Congress of the European Association of Urology

Fidia Farmaceutici announced the positive results of a Phase II study evaluating the efficacy and tolerability of Oncofid®PB, an innovative anti-cancer cell-directed paclitaxel-hyaluronan bioconjugate...

Biogen plans to present its advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting

Biogen Inc. announced that it will present at the Advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting. A plenary session titled “The Importance...

BioArctic Receives Regulatory Approval in Norway for a Clinical Study in Patients With Complete Spinal Cord Injury

BioArctic AB announced that the company has received approval by the Norwegian Medicines Agency (NOMA) departments for medicinal products and medical device and the...

Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market

There's a new tech partnership in diabetes, this time between Eli Lilly and Livongo. And it's looking to tap real-world data to deliver better...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...